COMMUNIQUÉS West-GlobeNewswire

-
Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting
29/01/2019 -
Extendicare Announces Timing of 2018 Fourth Quarter and Year End Results and Conference Call
29/01/2019 -
Momenta Pharmaceuticals Announces First Subject Dosed in Phase 1/2 Clinical Trial of M254, Hypersialylated Immunoglobulin G
29/01/2019 -
Oryzon to present at upcoming international conferences
29/01/2019 -
Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism
29/01/2019 -
Samumed to Present Novel Biological Targets of SM04690 for Treatment of Knee Osteoarthritis
29/01/2019 -
Spero Therapeutics Announces Initiation of SPR720 Phase 1 Clinical Trial
29/01/2019 -
scPharmaceuticals Inc. Announces Development Agreement with West Pharmaceutical Services for Next-Generation FUROSCIX® On-Body Infusor
29/01/2019 -
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder
29/01/2019 -
Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria
29/01/2019 -
Precipio Gains Recognition on NY Radio Station WHPC Show “My Hometown” As Innovator Battling Cancer Misdiagnosis
29/01/2019 -
Auris Medical to Redomicile Holding Company from Switzerland to Bermuda
29/01/2019 -
KemPharm Announces Enhancements to U.S. and Global Intellectual Property Estate
29/01/2019 -
National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors
29/01/2019 -
IMV Announces Clinical Update for DPX-Survivac Program in Ovarian Cancer Following Positive Feedback from U.S. FDA
29/01/2019 -
Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinson’s Disease and Friedreich’s Ataxia
29/01/2019 -
Aravive to Host Key Opinion Leader Breakfast Symposium on AVB-S6-500 and the GAS6-AXL Pathway on February 5, 2019
29/01/2019 -
FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy
29/01/2019 -
LHC Group Appoints National Healthcare Veteran Teri G. Fontenot to Board of Directors
29/01/2019
Pages